News
MRK
87.28
-0.87%
-0.77
18 out of 21 healthcare companies beat profit estimates this week- Earnings scorecard
Seeking Alpha · 21h ago
Notable healthcare headlines for the week: Eli Lilly, Merck and Becton, Dickinson in focus
Seeking Alpha · 23h ago
Trending stocks this week as markets assess tariffs, inflation news
Seeking Alpha · 1d ago
One 'Safer' Buy In 10 February Dogs Of The Dow
Seeking Alpha · 1d ago
What Moved Markets This Week
Seeking Alpha · 1d ago
Merck & Company Executives Make Bold Moves with Stock Transactions
TipRanks · 1d ago
AI Earnings, Tariff Threats, And Other Bellwether Stocks
Seeking Alpha · 2d ago
Trump Trade: President advocates to close carried interest tax loophole
TipRanks · 2d ago
Fund Update: Amundi Just Disclosed New Holdings
NASDAQ · 2d ago
Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards?
NASDAQ · 2d ago
Fund Update: AMF Tjanstepension AB Just Disclosed New Holdings
NASDAQ · 2d ago
Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings Update
Barchart · 2d ago
Wall Street Lunch: U.S. Could Ban DeepSeek On Government Devices
Seeking Alpha · 2d ago
White House readying order to fire thousands of federal health workers, WSJ says
TipRanks · 2d ago
AZN Q4 Earnings Lag, Sales Beat, Stock Up on China Probe Update
NASDAQ · 3d ago
The Merck & Co., Inc. (NYSE:MRK) Annual Results Are Out And Analysts Have Published New Forecasts
Simply Wall St · 3d ago
Top 3 Health Care Stocks You'll Regret Missing This Month
Benzinga · 3d ago
Bernstein Sticks to Its Hold Rating for Merck & Company (MRK)
TipRanks · 3d ago
Merck’s Broad Pipeline and Upcoming Catalysts Offer Upside Despite Investor Concerns
TipRanks · 3d ago
Evercore ISI Reaffirms Their Buy Rating on Merck & Company (MRK)
TipRanks · 3d ago
More
Webull provides a variety of real-time MRK stock news. You can receive the latest news about Merck & Co through multiple platforms. This information may help you make smarter investment decisions.
About MRK
Merck & Co., Inc. is a research-intensive biopharmaceutical company engaged in research to deliver health solutions that advance the prevention and treatment of diseases in people and animals. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. It is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.